Zobrazeno 1 - 10
of 496
pro vyhledávání: '"Subic, M."'
Autor:
Chouik Y; Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Lyon, France.; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.; University of Lyon Claude Bernard 1 (UCLB1), Lyon, France., Lebossé F; Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Lyon, France.; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.; University of Lyon Claude Bernard 1 (UCLB1), Lyon, France., Plissonnier ML; Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Lyon, France., Lega JC; Department of Internal Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France., Pradat P; Clinical Research Center, GHN, Hospices Civils de Lyon, Lyon, France., Antonini T; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France., Subic M; University of Lyon Claude Bernard 1 (UCLB1), Lyon, France., Hartig-Lavie K; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France., Erard D; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France., Villeret F; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.; University of Lyon Claude Bernard 1 (UCLB1), Lyon, France., Guichon C; Department of Anesthesiology and Intensive Care, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France., Payancé A; Université Paris-Cité, Inserm, Centre de recherche sur l'inflammation, UMR 1149, Paris, France., Radenne S; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France., Rautou PE; Université Paris-Cité, Inserm, Centre de recherche sur l'inflammation, UMR 1149, Paris, France.; Service d'Hépatologie, AP-HP, Hôpital Beaujon, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LIVER, Clichy, France., Zoulim F; Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Lyon, France.; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.; University of Lyon Claude Bernard 1 (UCLB1), Lyon, France., Levrero M; Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR5286, Lyon, France.; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.; University of Lyon Claude Bernard 1 (UCLB1), Lyon, France.; Department of Medicine SCIAC and the Italian Institute of Technology (IIT) Center for Life Nanosciences (CLNS), University of Rome La Sapienza, Rome, Italy.
Publikováno v:
IScience [iScience] 2023 Jul 20; Vol. 26 (8), pp. 107427. Date of Electronic Publication: 2023 Jul 20 (Print Publication: 2023).
Autor:
Lampertico, Pietro, Brunetto, Maurizia R., Craxì, Antonio, Gaeta, Giovanni B., Rizzetto, Mario, Rozzi, Antonella, Colombo, Massimo, Antonio, D., Andreone, P., Brancaccio, G., Bronte, F., Bruzzone, L., Caccamo, G., Caccianotti, B., Calvaruso, V., Chessa, L., Ciarallo, M., Coco, B., Colombatto, P., Cursaro, C., D'Aluisio, D., Demelia, L., Di Marco, V., Dissegna, D., Invernizzi, F., Lenisa, I., Lembo, T., Levrero, M., Marchese, V., Mangia, G., Picciotto, A., Pierconti, S., Raimondo, G., Rastelli, C., Rizzo, V., Santantonio, T., Scuteri, A., Sorbello, O., Squadrito, G., Subic, M., Toniutto, P., Vukotic, R.
Nucleos(t)ide analogues (NAs) and peginterferon have complementary effects in chronic hepatitis B, but it is unclear whether combination therapy improves responses in genotype D-infected patients. We conducted an open-label study of peginterferon alf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca1304382803b00551a45b1f5b18375
http://hdl.handle.net/11585/674496
http://hdl.handle.net/11585/674496
Autor:
Scholtès C; INSERM U1052 - Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France; Laboratoire de Virologie, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France. Electronic address: caroline.scholtes@inserm.fr., Hamilton AT; Roche Molecular Diagnostics, Pleasanton, CA, United States of America., Plissonnier ML; INSERM U1052 - Cancer Research Center of Lyon (CRCL), 69008 Lyon, France., Charre C; INSERM U1052 - Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France., Scott B; Roche Molecular Diagnostics, Pleasanton, CA, United States of America., Wang L; Roche Molecular Diagnostics, Pleasanton, CA, United States of America., Berby F; INSERM U1052 - Cancer Research Center of Lyon (CRCL), 69008 Lyon, France., French J; Department of Hepatology, Hospices Civils de Lyon, France., Testoni B; INSERM U1052 - Cancer Research Center of Lyon (CRCL), 69008 Lyon, France., Blair A; Roche Molecular Diagnostics, Pleasanton, CA, United States of America., Subic M; Department of Hepatology, Hospices Civils de Lyon, France., Hoppler M; Roche Diagnostics AG, Rotkreuz, Switzerland., Lankenau A; Roche Diagnostics AG, Rotkreuz, Switzerland., Grubenmann A; Roche Diagnostics AG, Rotkreuz, Switzerland., Levrero M; INSERM U1052 - Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France; Department of Hepatology, Hospices Civils de Lyon, France; Department of Internal Medicine, SCIAC and the IIT Center for Life Nanoscience, Sapienza University, Rome, Italy., Heil ML; Roche Molecular Diagnostics, Pleasanton, CA, United States of America., Zoulim F; INSERM U1052 - Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France; Department of Hepatology, Hospices Civils de Lyon, France.
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2022 Jun; Vol. 150-151, pp. 105150. Date of Electronic Publication: 2022 Apr 04.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tinti, F, Umbro, I, Palazzo, D, Biliotti, E, Bachetoni, A, Perinelli, P, Cappoli, A, D'Alessandro, Md, Grieco, S, Labriola, R, Subic, M, Rucci, P, Mitterhofer, Ap, Taliani, G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3686::367915235827c8e9a9fd0e4e06f5b04e
http://hdl.handle.net/11573/1390415
http://hdl.handle.net/11573/1390415
Autor:
Mikulski, Damian1,2, Kościelny, Kacper1, Dróżdż, Izabela3, Nowicki, Mateusz4,5, Misiewicz, Małgorzata5, Perdas, Ewelina1, Strzałka, Piotr4,5, Wierzbowska, Agnieszka4,5, Fendler, Wojciech1 wojciech.fendler@umed.lodz.pl
Publikováno v:
Infection & Chemotherapy. Sep2024, Vol. 56 Issue 3, p339-350. 12p.
Autor:
Testoni B; INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, UMR_S1052, CRCL, 69008 Lyon, France., Lebossé F; INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, UMR_S1052, CRCL, 69008 Lyon, France; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, France., Scholtes C; INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, UMR_S1052, CRCL, 69008 Lyon, France; Department of Virology, Croix Rousse Hospital, Hospices Civils de Lyon, France., Berby F; INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France., Miaglia C; INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, UMR_S1052, CRCL, 69008 Lyon, France; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, France., Subic M; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, France., Loglio A; Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy., Facchetti F; Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy., Lampertico P; Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy., Levrero M; INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, UMR_S1052, CRCL, 69008 Lyon, France; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, France; Department of Internal Medicine - DMISM and the IIT Center for Life Nanoscience (CLNS), Sapienza University, Rome, Italy., Zoulim F; INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, UMR_S1052, CRCL, 69008 Lyon, France; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, France. Electronic address: fabien.zoulim@inserm.fr.
Publikováno v:
Journal of hepatology [J Hepatol] 2019 Apr; Vol. 70 (4), pp. 615-625. Date of Electronic Publication: 2018 Dec 07.
Autor:
Palazzo, D., Biliotti, E., Tinti, F., Bachetoni, A., Volpicelli, L., Cappoli, A., D’Alessandro, M.D., Labriola, R., Perinelli, P., Grieco, S., Subic, M., Umbro, I., Rucci, P., Mitterhofer, A.P., Taliani, G.
Publikováno v:
In Digestive and Liver Disease 16 February 2017 49(1) Supplement:e67-e67
Autor:
Palazzo, D., Biliotti, E., Tinti, F., Bachetoni, A., Perinelli, P., Grieco, S., Cappoli, A., Subic, M., D’Alessandro, M.D., Labriola, R., Umbro, I., Rucci, P., Mitterhofer, A.P., Taliani, G.
Publikováno v:
In Digestive and Liver Disease 10 February 2016 48 Supplement 1:e4-e5